Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ASST vs IVZ

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ASST
Strive, Inc.

Asset Management

Communication ServicesNASDAQ • US
Market Cap$26M
5Y Perf.-90.7%
IVZ
Invesco Ltd.

Asset Management

Financial ServicesNYSE • US
Market Cap$11.92B
5Y Perf.+51.9%

ASST vs IVZ — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ASST logoASST
IVZ logoIVZ
IndustryAsset ManagementAsset Management
Market Cap$26M$11.92B
Revenue (TTM)$3M$6.38B
Net Income (TTM)$-217M$-243M
Gross Margin89.2%43.2%
Operating Margin-11.7%-10.9%
Forward P/E10.4x
Total Debt$4M$10.12B
Cash & Equiv.$67M$1.98B

ASST vs IVZLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ASST
IVZ
StockFeb 23May 26Return
Strive, Inc. (ASST)1009.3-90.7%
Invesco Ltd. (IVZ)100151.9+51.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: ASST vs IVZ

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IVZ leads in 5 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Strive, Inc. is the stronger pick specifically for growth and revenue expansion. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ASST
Strive, Inc.
The Growth Play

ASST is the clearest fit if your priority is growth exposure.

  • Rev growth 476.2%, EPS growth 98.6%, 3Y rev CAGR 119.9%
  • 476.2% revenue growth vs IVZ's 5.1%
Best for: growth exposure
IVZ
Invesco Ltd.
The Banking Pick

IVZ carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 4 yrs, beta 1.67, yield 3.1%
  • 22.1% 10Y total return vs ASST's -95.6%
  • Lower volatility, beta 1.67, Low D/E 77.9%, current ratio 43.01x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthASST logoASST476.2% revenue growth vs IVZ's 5.1%
Quality / MarginsIVZ logoIVZ-4.4% margin vs ASST's -74.6%
Stability / SafetyIVZ logoIVZBeta 1.67 vs ASST's 2.47
DividendsIVZ logoIVZ3.1% yield; 4-year raise streak; the other pay no meaningful dividend
Momentum (1Y)IVZ logoIVZ+93.1% vs ASST's -77.2%
Efficiency (ROA)IVZ logoIVZ-0.9% ROA vs ASST's -108.1%, ROIC -2.3% vs -40.0%

ASST vs IVZ — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ASSTStrive, Inc.

Segment breakdown not available.

IVZInvesco Ltd.
FY 2025
Investment Advice
72.4%$4.6B
Distribution and Shareholder Service
23.8%$1.5B
Financial Service, Other
3.2%$202M
Investment Performance
0.7%$42M

ASST vs IVZ — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIVZLAGGINGASST

Income & Cash Flow (Last 12 Months)

IVZ leads this category, winning 3 of 5 comparable metrics.

IVZ is the larger business by revenue, generating $6.4B annually — 2191.1x ASST's $3M. IVZ is the more profitable business, keeping -4.4% of every revenue dollar as net income compared to ASST's -74.6%.

MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
RevenueTrailing 12 months$3M$6.4B
EBITDAEarnings before interest/tax-$34M$1.2B
Net IncomeAfter-tax profit-$217M-$243M
Free Cash FlowCash after capex-$45M$1.9B
Gross MarginGross profit ÷ Revenue+89.2%+43.2%
Operating MarginEBIT ÷ Revenue-11.7%-10.9%
Net MarginNet income ÷ Revenue-74.6%-4.4%
FCF MarginFCF ÷ Revenue-15.6%+22.6%
Rev. Growth (YoY)Latest quarter vs prior year+56.8%
EPS Growth (YoY)Latest quarter vs prior year+89.9%+34.2%
IVZ leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

IVZ leads this category, winning 2 of 3 comparable metrics.
MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
Market CapShares × price$26M$11.9B
Enterprise ValueMkt cap + debt − cash-$38M$20.1B
Trailing P/EPrice ÷ TTM EPS-1.59x-16.77x
Forward P/EPrice ÷ next-FY EPS est.10.44x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.34x
Price / SalesMarket cap ÷ Revenue7.06x1.87x
Price / BookPrice ÷ Book value/share0.23x0.94x
Price / FCFMarket cap ÷ FCF8.27x
IVZ leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

IVZ leads this category, winning 6 of 9 comparable metrics.

IVZ delivers a -1.7% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-110 for ASST. ASST carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), IVZ scores 6/9 vs ASST's 3/9, reflecting solid financial health.

MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
ROE (TTM)Return on equity-110.0%-1.7%
ROA (TTM)Return on assets-108.1%-0.9%
ROICReturn on invested capital-40.0%-2.3%
ROCEReturn on capital employed-6.1%-2.6%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.02x0.78x
Net DebtTotal debt minus cash-$64M$8.1B
Cash & Equiv.Liquid assets$67M$2.0B
Total DebtShort + long-term debt$4M$10.1B
Interest CoverageEBIT ÷ Interest expense-186463.21x-6.19x
IVZ leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IVZ leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in IVZ five years ago would be worth $10,825 today (with dividends reinvested), compared to $435 for ASST. Over the past 12 months, IVZ leads with a +93.1% total return vs ASST's -77.2%. The 3-year compound annual growth rate (CAGR) favors IVZ at 21.6% vs ASST's -45.6% — a key indicator of consistent wealth creation.

MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
YTD ReturnYear-to-date-10.6%+0.4%
1-Year ReturnPast 12 months-77.2%+93.1%
3-Year ReturnCumulative with dividends-83.9%+79.8%
5-Year ReturnCumulative with dividends-95.6%+8.2%
10-Year ReturnCumulative with dividends-95.6%+22.1%
CAGR (3Y)Annualised 3-year return-45.6%+21.6%
IVZ leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

IVZ leads this category, winning 2 of 2 comparable metrics.

IVZ is the less volatile stock with a 1.67 beta — it tends to amplify market swings less than ASST's 2.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IVZ currently trades 90.6% from its 52-week high vs ASST's 5.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
Beta (5Y)Sensitivity to S&P 5002.47x1.67x
52-Week HighHighest price in past year$268.40$29.61
52-Week LowLowest price in past year$0.84$14.10
% of 52W HighCurrent price vs 52-week peak+5.8%+90.6%
RSI (14)Momentum oscillator 0–10064.869.4
Avg Volume (50D)Average daily shares traded3.6M5.1M
IVZ leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Consensus price targets imply 10.8% upside for IVZ (target: $30) vs -90.3% for ASST (target: $2). IVZ is the only dividend payer here at 3.10% yield — a key consideration for income-focused portfolios.

MetricASST logoASSTStrive, Inc.IVZ logoIVZInvesco Ltd.
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$1.50$29.72
# AnalystsCovering analysts28
Dividend YieldAnnual dividend ÷ price+3.1%
Dividend StreakConsecutive years of raises4
Dividend / ShareAnnual DPS$0.83
Buyback YieldShare repurchases ÷ mkt cap0.0%+15.6%
Insufficient data to determine a leader in this category.
Key Takeaway

IVZ leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.

Best OverallInvesco Ltd. (IVZ)Leads 5 of 6 categories
Loading custom metrics...

ASST vs IVZ: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is ASST or IVZ a better buy right now?

For growth investors, Strive, Inc.

(ASST) is the stronger pick with 476. 2% revenue growth year-over-year, versus 5. 1% for Invesco Ltd. (IVZ). Analysts rate Invesco Ltd. (IVZ) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ASST or IVZ?

Over the past 5 years, Invesco Ltd.

(IVZ) delivered a total return of +8. 2%, compared to -95. 6% for Strive, Inc. (ASST). Over 10 years, the gap is even starker: IVZ returned +22. 1% versus ASST's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ASST or IVZ?

By beta (market sensitivity over 5 years), Invesco Ltd.

(IVZ) is the lower-risk stock at 1. 67β versus Strive, Inc. 's 2. 47β — meaning ASST is approximately 48% more volatile than IVZ relative to the S&P 500. On balance sheet safety, Strive, Inc. (ASST) carries a lower debt/equity ratio of 2% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.

04

Which is growing faster — ASST or IVZ?

By revenue growth (latest reported year), Strive, Inc.

(ASST) is pulling ahead at 476. 2% versus 5. 1% for Invesco Ltd. (IVZ). On earnings-per-share growth, the picture is similar: Strive, Inc. grew EPS 98. 6% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ASST or IVZ?

Invesco Ltd.

(IVZ) is the more profitable company, earning -4. 4% net margin versus -591. 2% for Strive, Inc. — meaning it keeps -4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IVZ leads at -10. 9% versus -620. 7% for ASST. At the gross margin level — before operating expenses — IVZ leads at 43. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is ASST or IVZ more undervalued right now?

Analyst consensus price targets imply the most upside for IVZ: 10.

8% to $29. 72.

07

Which pays a better dividend — ASST or IVZ?

In this comparison, IVZ (3.

1% yield) pays a dividend. ASST does not pay a meaningful dividend and should not be held primarily for income.

08

Is ASST or IVZ better for a retirement portfolio?

For long-horizon retirement investors, Invesco Ltd.

(IVZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (3. 1% yield). Strive, Inc. (ASST) carries a higher beta of 2. 47 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IVZ: +22. 1%, ASST: -95. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between ASST and IVZ?

These companies operate in different sectors (ASST (Communication Services) and IVZ (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ASST is a small-cap high-growth stock; IVZ is a mid-cap income-oriented stock. IVZ pays a dividend while ASST does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ASST

High-Growth Disruptor

  • Sector: Communication Services
  • Market Cap > $100B
  • Revenue Growth > 28%
  • Gross Margin > 53%
Run This Screen
Stocks Like

IVZ

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 25%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ASST and IVZ on the metrics below

Revenue Growth>
%
(ASST: 56.8% · IVZ: 5.1%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.